A detailed history of Mesirow Financial Investment Management, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Mesirow Financial Investment Management, Inc. holds 11,610 shares of NVO stock, worth $1.3 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
11,610
Previous 10,847 7.03%
Holding current value
$1.3 Million
Previous $1.55 Million 10.72%
% of portfolio
0.03%
Previous 0.04%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$119.07 - $145.42 $90,850 - $110,955
763 Added 7.03%
11,610 $1.38 Million
Q2 2024

Aug 09, 2024

BUY
$122.71 - $146.91 $1.33 Million - $1.59 Million
10,847 New
10,847 $1.55 Million
Q1 2024

Apr 25, 2024

BUY
$102.11 - $135.92 $1.24 Million - $1.65 Million
12,157 New
12,157 $1.56 Million
Q4 2023

Feb 13, 2024

BUY
$87.78 - $105.45 $981,117 - $1.18 Million
11,177 New
11,177 $1.16 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $253B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Mesirow Financial Investment Management, Inc. Portfolio

Follow Mesirow Financial Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mesirow Financial Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mesirow Financial Investment Management, Inc. with notifications on news.